Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacture and marketing of quality finished dosages in domestic and international markets. Established in 1973 and headquartered in Mumbai-India, Ajanta committed to ‘Serve Health Care Needs Worldwide’. Ajanta has been consistently providing high quality affordable medicines to patients in different parts of the world. Anjanta pharma employ over 5,000 people worldwide and their products are sold in over 40 countries. Ajanta operates with five state-of-the art manufacturing facilities that produce high quality pharmaceutical products. Ajanta focuses on commercializing unique generic products and pioneering synergistic combination products in the therapeutic areas of anti-malarial, Cardiovascular, dermatology, male erectile dysfunction, musculoskeletal, and ophthalmology. In India, Ajanta has significant presence in the fast growing specialty therapeutic segments of Cardiovascular, dermatology, ophthalmology and musculoskeletal. With primary focus on new product innovation and introduction, we have been consistently identifying unmet medical needs and introducing many first-to-market products to cater to those needs. Ajanta products provide patient compliance and convenience over existing therapeutic options. Gaining first mover advantage, many of Ajanta brands hold leadership positions in their respective sub-therapeutic segments. Ajanta has extensive presence in many countries in Asia, Africa and Latin America with customized product portfolio to suit the needs of each country. Having successfully gone through USFDA inspection, they have started commercial operations in the US market in the first quarter of 2013. With a portfolio of 25 ANDAs which have been filed with the US FDA, they look forward to the US market to be their key growth driver in coming years.